Your browser doesn't support javascript.
loading
SLC6 transporter oligomerization.
Jayaraman, Kumaresan; Das, Anand K; Luethi, Dino; Szöllosi, Dániel; Schütz, Gerhard J; Reith, Maarten E A; Sitte, Harald H; Stockner, Thomas.
Afiliação
  • Jayaraman K; Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Das AK; Institute of Applied Physics, Vienna University of Technology, Vienna, Austria.
  • Luethi D; Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Szöllosi D; Institute of Applied Physics, Vienna University of Technology, Vienna, Austria.
  • Schütz GJ; Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Reith MEA; Institute of Applied Physics, Vienna University of Technology, Vienna, Austria.
  • Sitte HH; Department of Psychiatry, New York University School of Medicine, New York City, NY, USA.
  • Stockner T; Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
J Neurochem ; 157(4): 919-929, 2021 05.
Article em En | MEDLINE | ID: mdl-32767560
ABSTRACT
Transporters of the solute carrier 6 (SLC6) family mediate the reuptake of neurotransmitters such as dopamine, norepinephrine, serotonin, GABA, and glycine. SLC6 family members are 12 transmembrane helix-spanning proteins that operate using the transmembrane sodium gradient for transport. These transporters assume various quaternary arrangements ranging from monomers to complex stoichiometries with multiple subunits. Dopamine and serotonin transporter oligomerization has been implicated in trafficking of newly formed proteins from the endoplasmic reticulum to the plasma membrane with a pre-fixed assembly. Once at the plasma membrane, oligomers are kept fixed in their quaternary assembly by interaction with phosphoinositides. While it remains unclear how oligomer formation precisely affects physiological transporter function, it has been shown that oligomerization supports the activity of release-type psychostimulants. Most recently, single molecule microscopy experiments unveiled that the stoichiometry differs between individual members of the SLC6 family. The present overview summarizes our understanding of the influence of plasma membrane constituents on transporter oligomerization, describes the known interfaces between protomers and discusses open questions.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Transporte de Neurotransmissores Limite: Animals / Humans Idioma: En Revista: J Neurochem Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Transporte de Neurotransmissores Limite: Animals / Humans Idioma: En Revista: J Neurochem Ano de publicação: 2021 Tipo de documento: Article